| Dr Eric Maier Krause, MD, JD | |
|
419 W Redwood St Ste 300, Baltimore, MD 21201-7003 | |
| (410) 584-0428 | |
| Not Available |
| Full Name | Dr Eric Maier Krause |
|---|---|
| Gender | Male |
| Speciality | Thoracic Surgery |
| Experience | 13 Years |
| Location | 419 W Redwood St Ste 300, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285998328 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | D90013 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Maryland Medical Center | Baltimore, MD | Hospital |
| Umd Prince George's Hospital Ctr | Cheverly, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Maryland Surgical Associates Pa | 1658262472 | 86 |
| University Of Maryland Surgical Associates Pa | 1658262472 | 86 |
News Archive
Young patients who suffer patellar dislocations are at a higher risk of recurring dislocations, especially long-term after their initial injury, according to research presented today at the American Orthopaedic Society for Sports Medicine's Annual Meeting in Toronto, Ontario, Canada. Researchers received the Herodicus Award, presented to the best resident paper featured at the meeting, and determined by the Herodicus Society.
Pfizer Inc. today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) has been terminated in connection with the tender offer by its wholly-owned subsidiary, Parker Tennessee Corp., to purchase all outstanding shares of common stock of King Pharmaceuticals, Inc. for $14.25 per share, net to the seller in cash, without interest thereon and subject to any required withholding taxes.
People taking the blood pressure drugs called beta blockers may be less likely to have changes in the brain that can be signs of Alzheimer's disease and other types of dementia, according to a study released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.
LaunchPad Medical, LLC announced today that it has entered into a definitive agreement to license Stryker Corporation's bone adhesive technology, which is based on a unique synthetic biomaterial. Under the terms of the agreement, LaunchPad has received an exclusive worldwide license from Stryker for this technology which is covered by four issued and three pending U.S. patents and includes data from multiple pre-clinical animal studies.
Novira Therapeutics Inc. today announced it has secured $23 million in Series A financing to support the development of its capsid-targeting antivirals for the treatment of chronic hepatitis B (HBV) and HIV infections.
› Verified 6 days ago
| Entity Name | Shock Trauma Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679512909 PECOS PAC ID: 6800882317 Enrollment ID: O20040421000976 |
News Archive
Young patients who suffer patellar dislocations are at a higher risk of recurring dislocations, especially long-term after their initial injury, according to research presented today at the American Orthopaedic Society for Sports Medicine's Annual Meeting in Toronto, Ontario, Canada. Researchers received the Herodicus Award, presented to the best resident paper featured at the meeting, and determined by the Herodicus Society.
Pfizer Inc. today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) has been terminated in connection with the tender offer by its wholly-owned subsidiary, Parker Tennessee Corp., to purchase all outstanding shares of common stock of King Pharmaceuticals, Inc. for $14.25 per share, net to the seller in cash, without interest thereon and subject to any required withholding taxes.
People taking the blood pressure drugs called beta blockers may be less likely to have changes in the brain that can be signs of Alzheimer's disease and other types of dementia, according to a study released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.
LaunchPad Medical, LLC announced today that it has entered into a definitive agreement to license Stryker Corporation's bone adhesive technology, which is based on a unique synthetic biomaterial. Under the terms of the agreement, LaunchPad has received an exclusive worldwide license from Stryker for this technology which is covered by four issued and three pending U.S. patents and includes data from multiple pre-clinical animal studies.
Novira Therapeutics Inc. today announced it has secured $23 million in Series A financing to support the development of its capsid-targeting antivirals for the treatment of chronic hepatitis B (HBV) and HIV infections.
› Verified 6 days ago
| Entity Name | University Of Maryland Surgical Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962417634 PECOS PAC ID: 1658262472 Enrollment ID: O20040621000583 |
News Archive
Young patients who suffer patellar dislocations are at a higher risk of recurring dislocations, especially long-term after their initial injury, according to research presented today at the American Orthopaedic Society for Sports Medicine's Annual Meeting in Toronto, Ontario, Canada. Researchers received the Herodicus Award, presented to the best resident paper featured at the meeting, and determined by the Herodicus Society.
Pfizer Inc. today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) has been terminated in connection with the tender offer by its wholly-owned subsidiary, Parker Tennessee Corp., to purchase all outstanding shares of common stock of King Pharmaceuticals, Inc. for $14.25 per share, net to the seller in cash, without interest thereon and subject to any required withholding taxes.
People taking the blood pressure drugs called beta blockers may be less likely to have changes in the brain that can be signs of Alzheimer's disease and other types of dementia, according to a study released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.
LaunchPad Medical, LLC announced today that it has entered into a definitive agreement to license Stryker Corporation's bone adhesive technology, which is based on a unique synthetic biomaterial. Under the terms of the agreement, LaunchPad has received an exclusive worldwide license from Stryker for this technology which is covered by four issued and three pending U.S. patents and includes data from multiple pre-clinical animal studies.
Novira Therapeutics Inc. today announced it has secured $23 million in Series A financing to support the development of its capsid-targeting antivirals for the treatment of chronic hepatitis B (HBV) and HIV infections.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eric Maier Krause, MD, JD 306 W Redwood St Fl 4, Baltimore, MD 21201-1708 Ph: (667) 214-1734 | Dr Eric Maier Krause, MD, JD 419 W Redwood St Ste 300, Baltimore, MD 21201-7003 Ph: (410) 584-0428 |
News Archive
Young patients who suffer patellar dislocations are at a higher risk of recurring dislocations, especially long-term after their initial injury, according to research presented today at the American Orthopaedic Society for Sports Medicine's Annual Meeting in Toronto, Ontario, Canada. Researchers received the Herodicus Award, presented to the best resident paper featured at the meeting, and determined by the Herodicus Society.
Pfizer Inc. today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) has been terminated in connection with the tender offer by its wholly-owned subsidiary, Parker Tennessee Corp., to purchase all outstanding shares of common stock of King Pharmaceuticals, Inc. for $14.25 per share, net to the seller in cash, without interest thereon and subject to any required withholding taxes.
People taking the blood pressure drugs called beta blockers may be less likely to have changes in the brain that can be signs of Alzheimer's disease and other types of dementia, according to a study released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.
LaunchPad Medical, LLC announced today that it has entered into a definitive agreement to license Stryker Corporation's bone adhesive technology, which is based on a unique synthetic biomaterial. Under the terms of the agreement, LaunchPad has received an exclusive worldwide license from Stryker for this technology which is covered by four issued and three pending U.S. patents and includes data from multiple pre-clinical animal studies.
Novira Therapeutics Inc. today announced it has secured $23 million in Series A financing to support the development of its capsid-targeting antivirals for the treatment of chronic hepatitis B (HBV) and HIV infections.
› Verified 6 days ago
Dr. Richard F. Heitmiller, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 3333 N Calvert St, Johnston Prof Bldg, Ste 610, Baltimore, MD 21218 Phone: 410-554-2063 | |
Amanpreet Singh Sherwal, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 201 E University Pkwy, Department Of Surgery, Baltimore, MD 21218 Phone: 410-554-2734 Fax: 410-261-8085 | |
Dr. Peter W Cho, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 2435 W Belvedere Ave, Suite 35, Baltimore, MD 21215 Phone: 410-601-0900 Fax: 410-601-0901 | |
Glenn Whitman, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1800 Orleans St, Sheikh Zayed 7107 - Cardiac Surgery, Baltimore, MD 21287 Phone: 410-955-2800 Fax: 410-955-3809 | |
Dr. Michael Fiocco, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 201 E. University Parkway, Jpb Ll08, Baltimore, MD 21218 Phone: 410-554-6550 Fax: 410-554-6599 | |
Dr. Bradley Scott Taylor, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-328-5842 Fax: 410-328-2750 |